caprylates has been researched along with Stroke in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (66.67) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fernandes, RA; Ingle, AB | 1 |
Lally, C; Simpson, C; Steenland, K; Winquist, A | 1 |
Beland, DK; Bohannon, RW; Ohki, SK; Silverman, IE; Spiegel, GR | 1 |
Manev, H; Manev, R | 1 |
Kagamiishi, Y; Kamanaka, Y; Shimoda, T; Shinagawa, R | 1 |
Funakoshi, Y; Hiramatsu, M; Ishibashi, H; Pettigrew, LC | 1 |
2 review(s) available for caprylates and Stroke
Article | Year |
---|---|
Arundic acid a potential neuroprotective agent: biological development and syntheses.
Topics: Alzheimer Disease; Animals; Caprylates; Drug Discovery; Humans; Neuroprotective Agents; Parkinson Disease; Stroke | 2013 |
[Role of the astrocyte-specific protein S100B in acute stroke].
Topics: Animals; Astrocytes; Caprylates; Depression, Chemical; Free Radicals; Glutamic Acid; Humans; Inflammation Mediators; Nerve Growth Factors; Neuroprotective Agents; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Stroke | 2006 |
1 trial(s) available for caprylates and Stroke
Article | Year |
---|---|
Pharmacokinetics of arundic acid, an astrocyte modulating agent, in acute ischemic stroke.
Topics: Acute Disease; Adult; Age Factors; Aged; Aged, 80 and over; Area Under Curve; Astrocytes; Caprylates; Dose-Response Relationship, Drug; Double-Blind Method; Female; Half-Life; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neuroprotective Agents; Stroke | 2007 |
3 other study(ies) available for caprylates and Stroke
Article | Year |
---|---|
Relation between perfluorooctanoic acid exposure and strokes in a large cohort living near a chemical plant.
Topics: Aged; Caprylates; Chemical Industry; Cohort Studies; Confidence Intervals; Drinking Water; Environmental Exposure; Female; Fluorocarbons; Humans; Male; Middle Aged; Stroke; Water Pollutants, Chemical; Water Pollution | 2013 |
Expanding the range of therapies for acute ischemic stroke: the early experience of the Regional Stroke Center at Hartford Hospital.
Topics: Algorithms; Caprylates; Clinical Protocols; Connecticut; Fibrinolytic Agents; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Neuroprotective Agents; Stroke; Thrombectomy; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome | 2004 |
Could treatment with arundic acid (ONO-2506) increase vulnerability for depression?
Topics: Alzheimer Disease; Animals; Caprylates; Clinical Trials as Topic; Comorbidity; Depression; Disease Models, Animal; Fluoxetine; Humans; Nerve Growth Factors; Neuroprotective Agents; Risk Factors; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Stroke | 2006 |